The Effects of Artemisia Plant and Its Components Against Respiratory Viruses Like Influenza and Their Mechanisms of Action

AUTHORS

Asie Shojaii 1 , * , Roshanak Ghods 1

1 Iran University of Medical Sciences, Tehran, Iran

How to Cite: Shojaii A, Ghods R. The Effects of Artemisia Plant and Its Components Against Respiratory Viruses Like Influenza and Their Mechanisms of Action. Jundishapur J Nat Pharm Prod.In Press(In Press):e113060. doi: 10.5812/jjnpp.113060.

ARTICLE INFORMATION

Jundishapur Journal of Natural Pharmaceutical Products: In Press (In Press); e113060
Published Online: August 23, 2021
Article Type: Review Article
Received: January 19, 2021
Revised: May 31, 2021
Accepted: June 1, 2021
Uncorrected Proof scheduled for 16 (4)
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Context: Artemisia genus and its chemical constituents show antiviral activity against different viruses. The aim of this study was to review the effects of selected Artemisia species and their components against respiratory viruses like influenza and coronavirus.

Methods: All the articles published in English or Persian related to the effects of Artemisia and its components on viral respiratory infections and relevant mechanisms of action were searched throughout Medline, Science Direct, Scopus, Ebsco, Google Scholar, and Cochrane Library Database from 1966 up to April 2020.

Results: A few numbers of Artemisia species such as A. scoparia, A. rupestris, and A. annua and their components showed efficacy against the influenza virus and coronaviruses. Furthermore, some chemical compounds isolated from Artemisia species, like rupestonic acid, showed potent anti-influenza activity. The mechanism of antiviral activity was also determined for some of these compounds.

Conclusions: The present study summarized the efficacy of a number of Artemisia species and their components against respiratory viruses like influenza and coronavirus. Future studies on other Artemisia species may lead to the discovery of new antiviral drugs against the influenza virus and coronaviruses.

1. Context

Respiratory viruses are among the most common agents causing diseases in humans and have significant impacts on global morbidity and mortality rates (1). Although the influenza virus is the most prevalent viral infection associated with respiratory problems, other respiratory viruses may be responsible for substantial diseases in adults and the elderly (2). Some of these respiratory viruses include the adenovirus, human influenza virus, human bocavirus, human pneumovirus, human parainfluenza, human rhinovirus, human respiratory syncytial virus, severe acute respiratory syndrome (SARS) virus, and the coronavirus (COV) associated with SARS (SARS-COV).

Influenza is an acute infectious disease caused by a number of viruses belonging to the orthomyxovirus family. Influenza epidemics may lead to morbidity and mortality in the elderly and other high-risk patients (3). There are different types of influenza viruses including influenza virus type A, B, and to a much lesser extent, C. Although respiratory viruses are responsible for a variety of health problems in humans, no considerable preventive or therapeutic interventions are currently available for their associated diseases. Herbal medicine has an important role in the prevention and treatment of viral respiratory infections (VRI). Some of these herbs have a long history in the traditional medicine practices of different countries for treating respiratory diseases. These plants are generally used by patients with the common cold, viral pharyngitis, acute bronchitis, influenza, etc. (4).

Artemisia is a genus of the Compositae (Asteraceae) family and harbors more than 500 species, called ‘Worm wood’, ‘Mug word’, or ‘Tarragon’ (5). It is mainly distributed in the temperate zones of Europe, Asia, and North America, but Asia has the greatest share of these species (6). Different species of the genus Artemisia contain various chemical compounds, mainly flavonoids, terpenoids, coumarins, caffeoylquinic acids, acetylenes, and sterols (6). Also, Artemisia species are considered as good sources for volatile oils (5). These plants have a wide range of bioactivities such as antimalarial, cytotoxic, antihepatotoxic, antibacterial, antifungal, anti-diabetic (7-10), antispasmodic (11), antioxidant, and antiviral activities (12-14). The antiviral activity of this genus has been investigated against the Herpes Simplex virus, Hepatitis B Virus, Bovine viral diarrhea virus, and respiratory viruses (15-18). On the other hand, different compounds of Artemisia species have revealed various biological activities such as antimalarial, antibacterial, and antiviral effects. Some of these compounds, such as cirsimaritin, have potent effects against respiratory viral infections (19). Another known compound of Artemisia, artemisinin, is a sesquiterpene lactone isolated from some Artemisia species like A. annua and a potent antimalarial drug by acting against Plasmodium falciparum. Artemisinin derivatives have also shown various biological activities against the influenza virus (20).

The present review emphasizes the effects of Artemisia species and their components on viral respiratory infections (VRIs) and investigates their antiviral mechanisms. Also, this study suggests researchers to investigate the impacts of this genus and its active compounds against other viruses causing VRIs, like coronaviruses.

2. Methods

All the articles published in English or Persian, related to the efficacy and mechanisms of action of Artemisia species and their components in managing VRIs were searched in the Medline, Science Direct, Embase, Scopus, Ebsco, Google Scholar, and Cochrane Library databases from 1966 up to April 2020. The main keywords were Artemisia, viral, respiratory, influenza, coronavirus, component, mechanism, and infection.

3. Results and Discussion

According to the findings, different Artemisia species and their components showed potent antiviral activities against respiratory viruses such as the influenza virus and coronavirus (Table 1).

Table 1. Artemisia Species and Their Constituents Against Respiratory Viruses
Artemisia SpeciesArtemisia Extract or CompoundsType of VirusesReferences
A. annuaEthanolic extractSARS-CoV(21)
DihydroartemiseninInfluenza A
A. rupestrisRupestonic acidInfluenza A3(3)
6-demethoxy-4’-O- methylcapillarisin aromaticInfluenza A(22)
Rupestonic acid ester derivativesInfluenza A3(3)
Methyl esters of rupestonic acidInfluenza A (H1N1)(23)
A. scopariaExtractInfluenza virus(24)
CirsimaritinInfluenza A

3.1. Traditional Uses of Artemisia in Persian Medicine

Artemisia genus (Afsantin in Persian medicine) is known to have a hot and dry temperament in traditional medicine. Total heat produced by the extracts of this genus is greater than the whole plant, flowers, or seeds. They can dilates the blood vessels or dissolves thick or viscous matter to remove the obstruction (called "Mofatteh" in Persian medicine), show astringent, diuretics, appetizer, diaphoretic, and larvicidal effects, and purge serous bile that is collected in the stomach and strengthen the stomach. Avicenna believed that it is the best choice for treating gastric disorders, but it may cause headaches in susceptible patients (especially those with a hot temperament) and liquefies thick and viscous matters (called "Molattef" in Persian medicine)(25).

Artemisia has antipyretic effect and its decoction is a solution to chronic and compound fevers, intermittent fever, malaria fever, and phlegmatic disorders and can cleanse chest and lung vessels. It is also beneficial for colds, bronchitis, and influenza (26).

3.2. Artemisia Species Against Respiratory Viruses

3.2.1. Artemisia scoparia

Artemisia scoparia is one of the plants used in traditional Chinese medicine to prevent and treat fever, cough, and cold. Recent studies have shown that it has inhibitory activities against several influenza virus strains. Wang et al. (27) confirmed the in vitro and in vivo antiviral effects of A. scoparia extracts and determined their mechanisms of action against the influenza virus. They reported that Artemisia extract effectively intervened in influenza virus replication, decreased the activity of influenza virus neuraminidase, and reduced the expressions of the hemagglutinin and M2 proteins (27).

3.2.1.1. Active Components of A. scoparia

The active constituent of A. scoparia against the influenza virus is a flavonoid, cirsimaritin, whose inhibitory effect on the influenza virus is close to that of ribavirin or amantadine (27) (Figure 1). The influenza A virus (IAV) infection is associated with the activation of the nuclear factor kappa B (NF-κB) pathway, causing the overexpression of viral proteins. Also, studies revealed that the replication of influenza viruses could be elevated by the activation of the NF-κB signaling pathway (28-30).

Yan et al. (24) concluded that cirsimaritin could reduce IAV titer and its RNA and protein synthesis in a dose-dependent manner. Also, cirsimaritin promoted its anti-IAV activity via downregulating the phosphorylation of MAPKs (p38 and JNK) and suppressing the NF-kB signaling pathway, leading to a reduction in inflammatory cytokines such as IL-1β, IL-8, IL-10, and TNF-α (27).

3.2.2. Artemisia afra

Artemisia afra is one of the plants commonly used in the traditional medicine of South Africa to treat different illnesses such as coughs and colds, as well as sore throat and flus. Most commonly, A. afra fresh leaves are inserted into the nostrils to clear blocked nasal passages (31).

3.2.3. Artemisia rupestris

Artemisia rupestris L. is a perennial herb growing in China and also central Asian countries. It is used to treat colds in folk medicine (32). Zhang et al. (33) showed that the aqueous extract of A. rupestris could be an efficient adjuvant for influenza virus vaccines to boost immune responses and reduce the antigen doses required for triggering the immune system (33).

3.2.3.1. Active Compounds of A. rupestris

Rupestonic acid is a sesquiterpene isolated from A. rupestris, including multifunctional groups. It can inhibit the influenza virus to a moderate extent (23). In a study, a group of 2-substituted rupestonic acid methyl esters was synthesized to investigate their effects against the influenza virus, revealing potent activities against the 3b and 3c strains of the influenza H1N1 virus with the half-maximal inhibitory (IC50) concentrations of 2.12 and 1.71 µM, respectively (Figure 1) (23).

Figure 1. Chemical structures of anti-respiratory virus compounds from Artemisia species. A, rupestonic acid; B, circimaritin; C, dihydroartemisenin; D, 6-demethoxy-4’-O-methylcapillarisin; E, methyl esters of rupestonic acid; F, aromatic ester derivatives of rupestonic.

In another study, the fatty ester and aromatic ester derivatives of rupestonic acid showed significant antiviral activities against the A3 and B strains of the influenza virus. The highest inhibitory effect was observed against the influenza A3 virus (IC50 = 0.5 µmol/L) in exposure to one of the aromatic ester compounds, which was almost 10-fold higher than that of the reference drug, oseltamivir (Figure 1) (3).

The flavonoids extracted from A. rupestris showed inhibitory effects against viral infections. The antiviral properties of one of these flavonoids, 6-demethoxy-4’-O-methylcapillarisin (DMO-CAP), and its antiviral mechanism were studied against the IAV. Western blot analysis, qRT-PCR, and the luciferase assay were used to investigate the antiviral mechanisms of DMO-CAP against the IAV. According to the results, DMO-CAP revealed significant antiviral activities against the IAV in vitro by suppressing its replication via activating the Nrf2/heme-oxygenase-1 (HO-1) pathway. Subsequent to the up-regulation of HO-1 expression, the stimulation of the interferon (IFN) response induced the expression of IFN-stimulated genes, leading to efficient anti-IAV effects (22).

3.2.4. Artemisia annua

Artemisia annua L. is a medicinal plant harvested from Asia and Europe and is cultivated in Africa. It is used in Chinese traditional medicine for treating fever and chills (25). This plant is widely cultivated in Africa for treating malarial fever (5).

Li et al. (21) screened some herbal extracts against the SARS-COV, using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS) assay for the cytopathic effect (CPE) induced by the virus. The results showed that some of these extracts, including the components extracted from A. annua L., showed antiviral activity against the SARS-CoV in a Vero cell-based CPE/MTS screening assay. The half-maximal effective concentration (EC50) and 50% cytotoxic concentration (CC50) of the ethanolic extract were 34.5 ± 2.6 and 1035.0 ± 92.8 mg/mL, respectively (21).

3.2.4.1. Active Compounds of A. annua

Artemisinin (a sesquiterpene lactone) is an active constituent of A. annua, discovered in 1970. Due to artemisinin poor solubility in water and oil, its semisynthetic derivatives have been designed in appropriate formulations (20). The effect of dihydroartemisenin was studied against the influenza A virus, verifying its ability to inhibit the IAV by inducing the expression of tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6) in bronchial epithelial (BEAS-2B) cells through the extracellular signal-regulated kinase signaling pathway. The mRNA expression levels of TNF-α and IL-6, as well as the protein levels of TNF-α, IL-6, and phospho-ERK (p-ERK) were significantly up-regulated in the IAV group compared to the normal control group (P < 0.05). Likewise, a dose-dependent reduction in the mRNA levels of IL-6 and TNF-α and protein levels of TNF-α, IL-6, and p-ERK protein was seen in the IAV + dihydroartemisenin group compared to the IAV group (P < 0.05) (34).

4. Conclusions

The present review focused on the antiviral activities of Artemisia species and their constituents and summarized their impacts against respiratory viruses. The anti-virus components of some species, such as A. rupestris, A. scoparia, and A. annua, responsible for their effects against influenza viruses and coronaviruses, have been determined (21). The most important chemical compounds of Artemisia species against influenza viruses are flavonoids such as crisimaritin and sesquiterpenes like rupestonic acid. Since Artemisia species show significant activity against respiratory viruses, they can be proposed as good sources for effective drugs against influenza viruses and coronaviruses, including the causative agent of COVID-19. However, further investigations are necessitated to ascertain the best Artemisia species that are enriched in active compounds against influenza viruses and coronaviruses.

Footnotes

References

  • 1.

    Boncristiani H, Criado M, Arruda E. Encyclopedia of Microbiology. Academic Press; 2009.

  • 2.

    Shi T. The etiological role of common respiratory viruses in acute respiratory infections in older adults: A systematic review and meta-analysis. Eur Resp J. 2018;52(62):PA4504.

  • 3.

    Yong J, Aisa HA. Chemical Modification of Rupestonic Acid and Preliminarily In Vitro Antiviral Activity Against Influenza A3and B Viruses. Bull Korean Chem Soc. 2011;32(4):1293-7. doi: 10.5012/bkcs.2011.32.4.1293.

  • 4.

    Yarnell E. Herbs for Viral Respiratory Infections. Altern Complementary Ther. 2018;24(1):35-43. doi: 10.1089/act.2017.29150.eya.

  • 5.

    Koul B, Taak P. The Artemisia Genus: A Review on Traditional Uses, Phytochemical Constituents, Pharmacological Properties and Germplasm Conservation. J Glycomics Lipidomics. 2018;7(1). doi: 10.4172/2153-0637.1000142.

  • 6.

    Bora KS, Sharma A. The genus Artemisia: a comprehensive review. Pharm Biol. 2011;49(1):101-9. doi: 10.3109/13880209.2010.497815. [PubMed: 20681755].

  • 7.

    Mohammadian A, Moradkhani S, Ataei S, Shayesteh TH, Sedaghat M, Kheiripour N, et al. Antioxidative and hepatoprotective effects of hydroalcoholic extract of Artemisia absinthium L. in rat. J HerbMed Pharmacol. 2016;5(1):29-32.

  • 8.

    Obistioiu D, Cristina RT, Schmerold I, Chizzola R, Stolze K, Nichita I, et al. Chemical characterization by GC-MS and in vitro activity against Candida albicans of volatile fractions prepared from Artemisia dracunculus, Artemisia abrotanum, Artemisia absinthium and Artemisia vulgaris. Chem Cent J. 2014;8(1):6. doi: 10.1186/1752-153X-8-6. [PubMed: 24475951]. [PubMed Central: PMC3907663].

  • 9.

    Mojarrab MAHDI, Emami SA, Gheibi S, Taleb AM, Heshmati Afshar F. Evaluation of anti-malarial activity of Artemisia turcomanica and A. kopetdaghensis by cell-free β-hematin formation assay. Res J Pharmacogn. 2016;3(4):59-65.

  • 10.

    Nathar VN, Yatoo GM. Micropropagation of an antidiabetic medicinal plant, Artemisia pallens. Turk J Bot. 2014;38:491-8. doi: 10.3906/bot-1204-27.

  • 11.

    Taherkhani M. In vitro cytotoxic activity of the essential oil extracted from Artemisia absinthium. Iran J Toxicol. 2014;8(26):1152-6.

  • 12.

    Temraz A, El-Tantawy WH. Characterization of antioxidant activity of extract from Artemisia vulgaris. Pak J Pharm Sci. 2008;21(4):321-6. [PubMed: 18930849].

  • 13.

    Alesaeidi S, Miraj S. A Systematic Review of Anti-malarial Properties, Immunosuppressive Properties, Anti-inflammatory Properties, and Anti-cancer Properties of Artemisia Annua. Electron Physician. 2016;8(10):3150-5. doi: 10.19082/3150. [PubMed: 27957318]. [PubMed Central: PMC5133043].

  • 14.

    Michaelsen FW, Saeed ME, Schwarzkopf J, Efferth T. Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma. Phytomedicine. 2015;22(14):1223-31. doi: 10.1016/j.phymed.2015.11.001. [PubMed: 26655404].

  • 15.

    Saddi M, Sanna A, Cottiglia F, Chisu L, Casu L, Bonsignore L, et al. Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells. Ann Clin Microbiol Antimicrob. 2007;6:10. doi: 10.1186/1476-0711-6-10. [PubMed: 17894898]. [PubMed Central: PMC2099429].

  • 16.

    Karamoddini MK, Emami SA, Ghannad MS, Sani EA, Sahebkar A. Antiviral activities of aerial subsets of Artemisia species against Herpes Simplex virus type 1 (HSV1) in vitro. Asian Biomed. 2011;5(1):63-8.

  • 17.

    Geng CA, Yang TH, Huang XY, Yang J, Ma YB, Li TZ, et al. Anti-hepatitis B virus effects of the traditional Chinese herb Artemisia capillaris and its active enynes. J Ethnopharmacol. 2018;224:283-9. doi: 10.1016/j.jep.2018.06.005. [PubMed: 29890315].

  • 18.

    Romero MR, Serrano MA, Vallejo M, Efferth T, Alvarez M, Marin JJ. Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV). Planta Med. 2006;72(13):1169-74. doi: 10.1055/s-2006-947198. [PubMed: 16902856].

  • 19.

    Du Toit A, Van der Kooy F. Artemisia afra, a controversial herbal remedy or a treasure trove of new drugs? J Ethnopharmacol. 2019;244:112127.

  • 20.

    D'Alessandro S, Scaccabarozzi D, Signorini L, Perego F, Ilboudo DP, Ferrante P, et al. The Use of Antimalarial Drugs against Viral Infection. Microorganisms. 2020;8(1). doi: 10.3390/microorganisms8010085. [PubMed: 31936284]. [PubMed Central: PMC7022795].

  • 21.

    Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, et al. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005;67(1):18-23. doi: 10.1016/j.antiviral.2005.02.007. [PubMed: 15885816]. [PubMed Central: PMC7114104].

  • 22.

    Zhong M, Wang H, Ma L, Yan H, Wu S, Gu Z, et al. DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response. Virol J. 2019;16(1):21. doi: 10.1186/s12985-019-1125-9. [PubMed: 30786886]. [PubMed Central: PMC6381609].

  • 23.

    Obul M, Wang X, Zhao J, Li G, Aisa HA, Huang G. Structural modification on rupestonic acid leads to highly potent inhibitors against influenza virus. Mol Divers. 2019;23(1):1-9. doi: 10.1007/s11030-018-9840-5. [PubMed: 29971616].

  • 24.

    Yan H, Wang H, Ma L, Ma X, Yin J, Wu S, et al. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-kappaB signal transduction pathway. Virol J. 2018;15(1):88. doi: 10.1186/s12985-018-0995-6. [PubMed: 29783993]. [PubMed Central: PMC5963025].

  • 25.

    Aghili Khorasani M. Makhzan al-Advieh (The Storehouse of Medicaments). Tehran: Bavardaran Press; 2001. 546 p.

  • 26.

    Noorani M. The Great Encyclopedia of Islamic Medicine. Qom: Armaghan-e- yousef; 2005.

  • 27.

    Wang L, Si L, Li Y, Wang H, Xu F, Bian H, et al. Study on mechanism and active ingredient of Artemisia scoparia extracts against influenza virus. Lat Am J Pharm. 2017;36(7):1355-60.

  • 28.

    Flory E, Kunz M, Scheller C, Jassoy C, Stauber R, Rapp UR, et al. Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase. J Biol Chem. 2000;275(12):8307-14. doi: 10.1074/jbc.275.12.8307. [PubMed: 10722660].

  • 29.

    Pahl HL, Baeuerle PA. Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B. J Virol. 1995;69(3):1480-4. doi: 10.1128/JVI.69.3.1480-1484.1995. [PubMed: 7853480]. [PubMed Central: PMC188737].

  • 30.

    Wurzer WJ, Ehrhardt C, Pleschka S, Berberich-Siebelt F, Wolff T, Walczak H, et al. NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem. 2004;279(30):30931-7. doi: 10.1074/jbc.M403258200. [PubMed: 15143063].

  • 31.

    Snijders AJ. Medicinal plants of South Africa, 2nd edition, B-E Van Wyk, B van Oudshoorn and N Gericke : book review. J South Afr Vet Assoc. 2010;81(3). doi: 10.4102/jsava.v81i3.145.

  • 32.

    Nigam M, Atanassova M, Mishra AP, Pezzani R, Devkota HP, Plygun S, et al. Bioactive Compounds and Health Benefits ofArtemisiaSpecies. Nat Prod Commun. 2019;14(7). doi: 10.1177/1934578x19850354.

  • 33.

    Zhang A, Wang D, Li J, Gao F, Fan X. The effect of aqueous extract of Xinjiang Artemisia rupestris L. (an influenza virus vaccine adjuvant) on enhancing immune responses and reducing antigen dose required for immunity. PLoS One. 2017;12(8). e0183720. doi: 10.1371/journal.pone.0183720. [PubMed: 28841693]. [PubMed Central: PMC5571932].

  • 34.

    Ou L, Qin K, Yang ZX, Bie MJ. [The Effects and Mechanisms of Dihydroartemisinin on Influenza A Virus H1N1 Induces TNF-alpha and IL-6 Expression in Bronchial Epithelial Cells]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020;51(2):171-7. Chinese. doi: 10.12182/20200360604. [PubMed: 32220184].

  • Copyright © 2021, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE: